<DOC>
	<DOCNO>NCT02229760</DOCNO>
	<brief_summary>To determine effect steady-state tipranavir 500 mg/ritonavir 200 mg ( TPV/r ) intracellular concentration zidovudine triphosphate ( ZDV-TP ) carbovir triphosphate ( CBV-TP ) plasma viral load</brief_summary>
	<brief_title>Effect Steady State TPV/r Intracellular Concentrations Zidovudine Carbovir Patients With HIV</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Carbovir</mesh_term>
	<criteria>1 . Signed informed consent study participation 2 . Age &gt; 18 &lt; 60 year 3 . Female patient childbearing potential use barrier contraceptive method least 12 week administration study medication , study 28 day administration study medication end negative pregnancy test result 4 . Ability swallow capsule without difficulty 5 . A Body Mass Index ( BMI ) 18 29 kg/m2 6 . Reasonable probability complete study 7 . A medical history , physical examination , electrocardiogram ( ECG ) enter study 8 . Agreement abstain alcohol Day 2 Day 24 9 . Agreement abstain ingest grapefruit , grapefruit juice , Seville oranges orange marmalade Day 2 Day 24 10 . Negative urine drug screen drug abuse 11 . Documented HIV1 RNA load ( PCR ) screen &lt; 50 copies/mL least 3 month stable ZDV ABC regimen least 6 month . Acceptable documentation include laboratory data , letter , verbal report another provider note patient 's record 12 . All HIVinfected patient must TPV na√Øve must receive PI base regimen within 6 month enrollment 1 . Female patient positive serum pregnancy test screen period Day 14 Day 7 plan breastfeed time ( Day 0 30 TPV/r administration ) 2 . Use investigational medicine within 30 day Day 0 3 . Use known CYP3A4 alter drug ( i.e. , phenothiazine , cimetidine , barbiturate , ketoconazole , fluconazole , rifampin , steroid herbal medication ) within 30 day Day 0 . No antibiotic permit within 10 day Day 0 4 . Ingestion grapefruit , grapefruit juice , Seville oranges , orange marmalade within 2 day study entry ( Day 0 ) 5 . Blood plasma donation ( &gt; 100 mL total ) research altruistic reason within 30 day Day 0 6 . Seated systolic blood pressure either &lt; 100 mm Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/minute &gt; 90 beats/minute 7 . History illness ( include malabsorption , irregular food intake , gastrointestinal intolerance , allergy ) , opinion investigator , might confound result study pose additional risk administer TPV/r 8 . Any acute illness within 2 week Day 0 9 . Patients currently take overthecounter medication within 7 day Day 0 , currently take prescription drug , opinion investigator ( consultation BI medical monitor pharmacokineticist ) , would interfere either absorption , distribution , metabolism TPV ritonavir 10 . Hypersensitivity TPV , ritonavir , sulfonamide contain drug , antiretroviral drug ( market experimental use part clinical research study ) 11 . Sulfonamide allergy , opinion investigator , might confound result study pose additional risk administer TPV/r 12 . Any laboratory value outside normal reference range clinical relevance screening , accord judgment investigator ( i.e. , aspartate aminotransferase alanine aminotransferase level 2.5fold 2.5fold high upper normal limit , respectively ) 13 . Based compliance diary , patient less 100 % document compliance 714 day background Antiretroviral ( ARV ) ( i.e. , ZDV ABC ) medication Day 5 0 ( visit 2 ) 14 . Use protease inhibitor ( i.e. , fosamprenavir , amprenavir , indinavir , saquinavir , lopinavir , ritonavir , atazanavir , nelfinavir ) within 6 month enrollment 15 . Patients coinfected active Hepatitis B and/or C determine hepatitis serology . 16 . Use antiplatelet medication ( e.g . aspirin , dipyridamole , clopidogrel , counter antiplatelet medicine ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>